AMSTERDAM – A single-center review of thrombotic events in lupus patients showed a doubling of DVT risk when vitamin D levels fell below a certain...
From the Journals
Stricter blood management practices and VTE prophylaxis may be needed if the study findings are confirmed.
WASHINGTON – The preferred evaluation – intravascular ultrasound – was not used.
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
SAN DIEGO – About half of hemostasis/thrombosis research is basic in nature.
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.
SEATTLE – Thromboelastometry can play a role in identifying bariatric surgery patients at risk for VTE.
Daily News Podcast
And there’s new promise in early-stage lung cancer.